VPHIF (Valeo Pharma) Total Inventories: $3.60 Mil (As of Jul. 2024)


VPHIF Valeo Pharma Inc VPHIF
12 GF Score
Price $0.00
View Full Analysis

What is Valeo Pharma Total Inventories?

Valeo Pharma VPHIF -99.00% 12 Total Inventories is $3.60 Mil as of Jul. 2024. GuruFocus rates VPHIF with a GF Score™ of 12/100.

Valeo Pharma's total inventories for the quarter that ended in Jul. 2024 was $3.60 Mil. Valeo Pharma's average total inventories from the quarter that ended in Apr. 2024 to the quarter that ended in Jul. 2024 was $4.22 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Valeo Pharma's Net-Net Working Capital per share for the quarter that ended in Jul. 2024 was $-0.61.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Valeo Pharma's Days Inventory for the three months ended in Jul. 2024 was 55.14.

Inventory Turnover measures how fast the company turns over its inventory within a year. Valeo Pharma's Inventory Turnover for the quarter that ended in Jul. 2024 was 1.65.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Valeo Pharma's Inventory-to-Revenue for the quarter that ended in Jul. 2024 was 0.46.

Valeo Pharma  (OTCPK:VPHIF) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Valeo Pharma's Net-Net Working Capital Per Share for the quarter that ended in Jul. 2024 is

Net-Net Working Capital Per Share (Q: Jul. 2024 )
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(5.195+0.75 * 3.344+0.5 * 3.6-69.439
-0-0)/98.675
=-0.61

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Valeo Pharma's Days Inventory for the three months ended in Jul. 2024 is calculated as:

Days Inventory=Average Total Inventories (Q: Jul. 2024 )/Cost of Goods Sold (Q: Jul. 2024 )*Days in Period
=4.2155/6.976*365 / 4
=55.14

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Valeo Pharma's Inventory Turnover for the quarter that ended in Jul. 2024 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Jul. 2024 ) / Average Total Inventories (Q: Jul. 2024 )
=6.976 / 4.2155
=1.65

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Valeo Pharma's Inventory to Revenue for the quarter that ended in Jul. 2024 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Jul. 2024 ) / Revenue (Q: Jul. 2024 )
=4.2155 / 9.188
=0.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Valeo Pharma Total Inventories Related Terms

Valeo Pharma Total Inventories Historical Data

* Premium members only.

The historical data trend for Valeo Pharma's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Valeo Pharma Total Inventories Chart

Valeo Pharma Annual Data
Trend Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Total Inventories
Get a 7-Day Free Trial 0.43 0.67 6.17 7.29 7.47

Valeo Pharma Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
Total Inventories Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.75 7.47 7.23 4.83 3.60
VPHIF
12GF Score
Valeo Pharma Inc VPHIF
Total Inventories is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Valeo Pharma Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Frequently Asked Questions Learn more about Total Inventories →
What does a Total Inventories of $3.60 Mil mean?
Valeo Pharma (VPHIF) has a Total Inventories of $3.60 Mil as of Jul. 2024. The total amount of inventory as recorded on a company's balance sheet. View historical data for Valeo Pharma and its competitors.
Is Valeo Pharma's Total Inventories too high?
Valeo Pharma's current Total Inventories is $3.60 Mil. Overall, Valeo Pharma has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Valeo Pharma's Total Inventories compare to ZTS?
Valeo Pharma's Total Inventories of $3.60 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Drug Manufacturers company?
A good Total Inventories depends on the Drug Manufacturers industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for Valeo Pharma and its competitors. Valeo Pharma's current Total Inventories is $3.60 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Valeo Pharma stock overvalued right now?
Valeo Pharma (VPHIF) has a current Total Inventories of $3.60 Mil. The current Total Inventories is $3.60 Mil. Valeo Pharma's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For Valeo Pharma (VPHIF), the current Total Inventories is $3.60 Mil as of Jul. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Valeo Pharma Business Description

Address 16667, Hymus Boulevard, Kirkland, QC, CAN, H9H 4R9
Valeo Pharma Inc is a Canadian specialty pharmaceutical company focused on acquiring either through acquisitions, in-licensing, or similar arrangements. The company operates in two divisions: Branded prescription products and hospital specialty products. Its product portfolio includes medicines for Respiratory/Allergy, Ophthalmology, Neurology, and Oncology.
12GF Score

Get the complete analysis for VPHIF

Total Inventories is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price